MIHDF yields 6.41% · JNJ yields 2.13%● Live data
📍 MIHDF pulled ahead of the other in Year 1
Combined, MIHDF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MIHDF + JNJ for your $10,000?
MISC Berhad provides energy-related maritime solutions and services worldwide. The company operates through LNG (liquefied natural gas) Asset Solutions, Petroleum & Product Shipping, Offshore Business, Marine & Heavy Engineering, and Others segments. It owns and operates LNG carriers; petroleum and chemical tankers; and floating storage and offloading, and mobile offshore production units; and semi-submersible floating production systems. The company is also involved in the provision of marine and heavy engineering services, including engineering, procurement, construction, installation, and commissioning services for offshore and onshore construction; and marine repair and conversion works. In addition, it offers maritime education and training services for seamen and maritime personnel; port and terminal services; marine transportation; integrated marine services; and crew management and dry docking of marine vessels services. Further, the company operates and manages the Sungai Udang Port; and owns properties. As of February 17, 2022, it operated a fleet of approximately 100 owned and in-chartered comprising of LNG, petroleum, and product vessels; floating production systems; and LNG floating storage units with a combined deadweight tonnage capacity of approximately 13 million tonnes. The company was incorporated in 1968 and is headquartered in Kuala Lumpur, Malaysia. MISC Berhad operates as a subsidiary of Petroliam Nasional Berhad.
Full MIHDF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.